{
  "id": "clinical#screening_cues_c01d2eb5",
  "content": "disorder, the diagnosis is F13.282 severe lorazepam use disorder with\nlorazepam-induced sleep disorder, with onset during withdrawal,\ninsomnia type. A separate diagnosis of the comorbid severe loraze-\npam use disorder is not given. If the substance-induced sleep disor-\nder occurs without a comorbid substance use disorder (e.g., with\nmedication use), no accompanying substance use disorder is noted\n(e.g., F19.982 bupropion-induced sleep disorder, with onset during\nmedication use, insomnia type). When more than one substance is\njudged to play a significant role in the development of the sleep dis-\nturbance, each should be listed separately (e.g., F10.282 severe alco-\nhol use disorder with alcohol-induced sleep disorder, with onset\nduring intoxication, insomnia type; F14.282 severe cocaine use disor-\nder with cocaine-induced sleep disorder, with onset during intoxica-\ntion, insomnia type).\nOther Specified Insomnia Disorder\n780.52 (G47.09)\nThis category applies to presentations in which symptoms character-\nistic of insomnia disorder that cause clinically significant distress or\nimpairment in social, occupational, or other important areas of func-\ntioning predominate but do not meet the full criteria for insomnia dis-\n198 Sleep-Wake Disorders\norder or any of the disorders in the sleep-wake disorders diagnostic\nclass. The other specified insomnia disorder category is used in situ-",
  "metadata": {
    "source": "DSM-5",
    "url": "https://psychiatry.org/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "sleep",
      "stress",
      "screening_cues",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues disorder, the diagnosis is F13.282 severe lorazepam use disorder with\nlorazepam-induced sleep disorder, with onset during withdrawal,\ninsomnia type. A separate diagnosis of the comorbid severe loraze-\npam use disorder is not given. If the substance-induced sleep disor-\nder occurs without a comorbid substance use disorder (e.g., with\nmedication use), no accompanying substance use disorder is noted\n(e.g., F19.982 bupropion-induced sleep disorder, with onset during\nmedication use, insomnia type). When more than one substance is\njudged to play a significant role in the development of the sleep dis-\nturbance, each should be listed separately (e.g., F10.282 severe alco-\nhol use disorder with alcohol-induced sleep disorder, with onset\nduring intoxication, insomnia type; F14.282 severe cocaine use disor-\nder with cocaine-induced sleep disorder, with onset during intoxica-\ntion, insomnia type).\nOther Specified Insomnia Disorder\n780.52 (G47.09)\nThis category applies to presentations in which symptoms character-\nistic of insomnia disorder that cause clinically significant distress or\nimpairment in social, occupational, or other important areas of func-\ntioning predominate but do not meet the full criteria for insomnia dis-\n198 Sleep-Wake Disorders\norder or any of the disorders in the sleep-wake disorders diagnostic\nclass. The other specified insomnia disorder category is used in situ- Disorder, the diagnosis is f13.282 severe lorazepam use disorder with\nlorazepam-induced giấc ngủ disorder, with onset during withdrawal,\ninsomnia type. a separate diagnosis of the comorbid severe loraze-\npam use disorder..."
}